Xvivo Perfusion AB
XVIVO.ST · Health Technology · Medical Specialties · SE
59 employees · xvivoperfusion.com
About
Xvivo Perfusion AB is a Swedish medical technology company that specializes in the development of solutions aimed at improving the transplantation of human organs. The company was founded in 1998 by Tetsuzo Akutsu, a renowned Japanese heart surgeon specializing in the treatment of cardiovascular diseases.
Annual results
Reported figures, SEK · revenue down 1.2% in 2025
| Year | Revenue | Net income | Net margin | Free cash flow |
|---|---|---|---|---|
| 2025 | 812M | 25.0M | 3.1% | — |
| 2024 | 822M | 172M | 20.9% | — |
| 2023 | 597M | 91.0M | 15.2% | — |
| 2022 | 415M | 18.0M | 4.3% | — |
| 2021 | 258M | 8.0M | 3.1% | — |
XVIVO.ST in MarketPulse
The live chart with RSI and moving averages, the price, news, signals and price alerts for Xvivo Perfusion AB are inside MarketPulse — currently in private beta.
Company data by Eulerpool. Logos provided by Elbstream. Reported figures, not investment advice.